Skyward Group Leverages Apollo Acquisition to Expand Skyward Specialty's Life Sciences Solution Globally

Core Viewpoint - Skyward Group has announced the global expansion of its Life Sciences insurance solution, leveraging Apollo's Lloyd's Syndicate 1969 to enhance multinational placements for U.S.-domiciled life sciences companies with international operations [1][2]. Group Overview - Skyward Group operates as a unified specialty insurance organization, encompassing Skyward Specialty and Apollo, and provides a comprehensive suite of specialized insurance solutions across global specialty property and casualty markets [3][4]. - The company focuses on niche and complex risks, aiming to drive sustainable growth and long-term value for shareholders and stakeholders [3]. Strategic Collaboration - The expansion of the Life Sciences product is the first strategic collaboration between Skyward Specialty and Apollo since the acquisition was finalized earlier in January 2026 [1][2]. - The collaboration is expected to leverage the complementary capabilities of both organizations, enhancing their ability to support specialty risks on a global scale [2]. Product Offerings - Skyward Specialty provides a range of commercial property and casualty products through nine underwriting divisions, including Accident & Health, Agriculture, and Professional Lines [5]. - The insurance companies under Skyward Specialty are rated A (Excellent) with a stable outlook by A.M. Best Company, indicating a strong financial position [6]. Apollo's Role - Apollo operates as an innovation-inspired insurance platform at Lloyd's of London, offering data-driven solutions across various risk categories, including Property, Casualty, and Specialty [7]. - The platform aims to provide high-quality products and services, enabling a resilient and sustainable world [7].